Japan, March 3 -- SANOFI BIOTECHNOLOGY has got intellectual property rights for 'ANTI-IL-1R3 ANTIBODIES FOR USE IN INFLAMMATORY CONDITIONS.' Other related details are as follows:
Application Number: JP,2024-216380
Category (FI): A61K39/395@D,A61K39/395@N,A61P29/00,A61P31/00,C07K16/18,C07K16/24,C07K16/28
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Dec. 11, 2024
Publication Date: March 18, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
